Advances in the Battle Against Methicillin-Resistant Staphylococcus aureus
Staphylococcus aureus is an opportunistic pathogen that asymptomatically colonizes the skin and mucosal surfaces. The organism causes infections that range from minor skin conditions to pneumonia and...
View ArticleBipolar Disorder: New Approaches in the Treatment of Depressive Episodes
This program highlights evolving evidence on the efficacy and safety of novel treatment options for patients with bipolar depression.
View ArticleFDA Approves a New 4-in-1 Pharmacologic Agent to Improve Efficacy, Safety,...
Pill burden and treatment regimen complexity are strong factors related to adherence among patients with HIV, but once-daily fixed-dose combinations (FDCs) can help to overcome these burdens, increase...
View ArticleNeuroprotection in Amyotrophic Lateral Sclerosis: Novel Therapeutic Evidence
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrigandrsquo;s Disease, is a rapidly progressive and eventually fatal neurodegenerative disease of motor neurons in the brain and spinal cord,...
View ArticleAndrogen Receptor Inhibition for Castrate-Resistant Prostate Cancer: Focus on...
Treatment choices for men with CRPC have been limited until recently. For more than a decade, docetaxel in combination with prednisone has been the treatment of choice for the treatment of CRPC.4...
View ArticleContemporary Approaches to Induce and Maintain Clinical Remission in Adult...
This article focuses on contemporary approaches in achieving treatment goals for Crohn's disease, and provides perspectives on the utilization of conventional and biologic therapies to achieve and...
View ArticleImproving Bleeding Control and Treatment Burden in Patients with Hemophilia...
This activity reviews recent evidence on current and emerging recombinant clotting factors for treating hemophilia A. Novel therapies show promise in improving patient outcomes through enhanced...
View ArticleNew Developments in Treatment Approaches for Patients with Partial-Onset...
This activity reviews information on newly approved medications for the treatment of partial-onset seizures associated with epilepsy.
View ArticleLate-Stage Developments in Enzyme Replacement Therapy for...
This activity reviews up-to-date information on phase III clinical trial findings for enzyme replacement therapy for the treatment of mucopolysaccharidosis IVA (MPS IVA), also known as Morquio A.
View ArticleLifetime Intellectual Enrichment Activities May Delay Cognitive Decline in...
recently published study in JAMA Neurology showed that cognitive declines associated with Alzheimer's disease may be delayed by up to 9 years in older adults with high levels of education, occupation,...
View Article
